Brivaracetam

Overview

Brivaracetam is an anticonvulsant medication used to treat epilepsy. It is a derivative of levetiracetam with a racetam chemical structure.

API suppliers (1)

Suppliers of Brivaracetam backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• YANGZHOU LIBERTY PHARMACEUTICAL CO LTDChina2 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (42 approved US products), the latest listed US patent on Brivaracetam expires 8 Apr 2030. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-one

Canonical SMILES

C(C(C1C(C(C(=O)O1)O)O)O)O

InChIKey

SXZYCXMUPBBULW-UHFFFAOYSA-N

Therapeutic areas